Long-term Toxicity Monitoring
Long-Term Toxicity Monitoring is a systematic clinical surveillance framework designed to detect, assess, and manage delayed adverse effects of medical treatments over extended post-intervention periods.
134
Publications
7.5K
Citations
911
Authors
372
Institutions
Publications per year
2017–2026
34
Parents
134
EMA/CO for high-risk gestational trophoblastic tumors: results from a cohort of 272 patients.
Mark Bower, E.S. Newlands, L. Holden et al. · Journal of Clinical Oncology · 1997 · 311 citations
Medicine, Gynecology, Oncology +17
Evaluation of long-term toxicity after chemotherapy for testicular cancer.
Carsten Bokemeyer, C. Berger, M. Kuczyk et al. · Journal of Clinical Oncology · 1996 · 268 citations
Medicine, Oncology, Pharmacology +15
1–5 of 134
911
3
h-index
3
h-index
3
h-index
3
h-index
2
h-index
1–5 of 911
372
The University of Texas MD Anderson Cancer Center
Houston, United States
6 h-index
23 publications
523 citations
Memorial Sloan Kettering Cancer Center
New York, United States
6 h-index
37 publications
4.8K citations

Washington University in St. Louis
St Louis, United States
5 h-index
10 publications
495 citations
Mayo Clinic in Arizona
Scottsdale, United States
4 h-index
14 publications
1.1K citations

Cornell University
Ithaca, United States
4 h-index
17 publications
2.1K citations
Mayo Clinic
Rochester, United States
3 h-index
9 publications
798 citations
Royal Prince Alfred Hospital
Sydney, Australia
3 h-index
7 publications
255 citations
St Vincent's Hospital Sydney
Darlinghurst, Australia
3 h-index
11 publications
213 citations
1–8 of 372
12 publications · 1.4K citations
11
h-index
8 publications · 406 citations
8
h-index
Repository · 6 publications · 108 citations
6
h-index
4 publications · 421 citations
4
h-index
4 publications · 340 citations
4
h-index
1–5